Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as a strong validation of the value it brings ...

Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascul…

Conference call and live webcast to be held Monday, May 18th at 3:00pm ET Wall Street firm publishes research report refuting ...
Nasdaq

Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

Global Robotic Leaders Convene to Discuss & Highlight Surgical Advancements of the Next Decade with a Special Focus on the Endovascular Space HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot ...

Microbot Medical Begins Full U.S. Launch of LIBERTY System

MBOT moves to full U.S. launch of its LIBERTY robotic system after strong hospital adoption, boosting momentum for faster market uptake and sales growth.
Nasdaq

Microbot Medical Inc. Achieves Key Milestones in Preparation for LIBERTY® Endovascular Robotic System Launch

Microbot Medical Inc. announces key milestones, including FDA 510(k) submission, in preparation for LIBERTY's commercial launch in 2025. Microbot Medical Inc. announced the successful completion of ...
Seeking Alpha

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

HINGHAM, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer and distributer of the innovative LIBERTY ® Endovascular Robotic System, today announced that it will be ...

Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic ...

Conference call and live webcast to be held Monday, May 18th at 3:00pm ETWall Street firm publishes research report refuting claims made by ...